NCT04369417

Brief Summary

The proposed research has the following objectives: Based off findings from the "Development of a Resiliency Program for Siblings of Children with Autism Spectrum Disorder" qualitative focus group study (protocol 2019P002284), the aim is to determine the feasibility and acceptability, of an 8-session Relaxation Response Resiliency (SibChat) program for siblings of children with ASD. We primarily aim to test the preliminary effectiveness of a pilot waitlist controlled trial on improving resiliency and stress coping, This will be assessed by comparing Baseline-3 mo. scores on primary and secondary outcome measures between the Immediate and Waitlist control groups. Among participants randomized to both conditions, we secondarily aim to investigate the extent of pre-post changes in primary and secondary outcomes. Among immediate condition group only, we also aim to assess whether end-of-treatment (3 mo. post enrollment) improvements will be sustained at 6-mo. post enrollment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2020

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

February 20, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 30, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

April 5, 2022

Status Verified

April 1, 2022

Enrollment Period

11 months

First QC Date

February 20, 2020

Last Update Submit

April 4, 2022

Conditions

Keywords

Resiliency TrainingAutism Spectrum DisorderFamily Relationships

Outcome Measures

Primary Outcomes (7)

  • Feasibility assessed by the number participants enrolled.

    We will assess study feasibility based on number of participants enrolled in the study (target N=40)

    6 months

  • Feasibility assessed by the number SibChat-3RP of sessions attended

    Whether youth attended at least 5 out of 8 total program sessions.

    8 weeks

  • Feasibility assessed by the survey retention post intervention.

    Among participants randomized to both conditions, feasibility is assessed by the number of participants who completed the T2 and T3 surveys, 3 months and 6 months post baseline, respectively.

    6 months

  • Acceptability assessed using the participant feedback survey

    The participant feedback survey is a questionnaire made up of likert scales and open ended questions designed to record acceptability of the SibChat-3RP program on topics including length of sessions, number of sessions, and virtual delivery.

    3 months

  • Acceptability assessed by relaxation response adherence

    Among participants randomized to both conditions, relaxation response adherence is measured at T1, T2 and T3. Relaxation response adherence is a 1-item likert scale that indicates how often participants practice relaxation response exercises. Acceptability is determined based on whether participants indicate that they practice relaxation response exercises at least bimonthly 3 months post intervention.

    3 months

  • Effectiveness of trial on improving stress coping ability (assessed using Measure of Current Status-A)

    Measure of Current Status-A is a questionnaire - the score on the questionnaire is used to indicate stress coping ability. A change in score indicates a change in indicated stress coping ability. Comparison of intervention and wait list control 3 months after baseline (T1).

    3 months

  • Effectiveness of trial on improving resiliency (assessed using Current Experiences Scale)

    Current experiences Scale is a questionnaire. Improved resiliency is measured base upon change in questionnaire score. Comparison of intervention and wait list control 3 months after baseline (T1).

    3 months

Secondary Outcomes (2)

  • Pre-post intervention changes as measured by change in primary outcome scores of resiliency and stress coping.

    3 months

  • Sustained improvements in primary outcomes of resiliency and stress coping as measured by sustained change in primary outcome scores.

    3 months

Study Arms (2)

Experimental: 3RP treatment

EXPERIMENTAL

An adapted version of the Relaxation Response Resiliency Program (3RP) for siblings of children with ASD. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies.

Behavioral: Relaxation Response Resiliency Program for Siblings of Children with ASD

Active Comparator: Waitlist control

ACTIVE COMPARATOR

An adapted version of the Relaxation Response Resiliency Program (3RP) for siblings of children with ASD. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies.

Behavioral: Relaxation Response Resiliency Program for Siblings of Children with ASD

Interventions

Virtually delivered psycho-educational resiliency training program for teenage siblings of children with ASD.

Active Comparator: Waitlist controlExperimental: 3RP treatment

Eligibility Criteria

Age14 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 14-17 years (inclusive of ages 14 and 17)
  • Being the sibling of at least one individual with ASD
  • Access to internet or smart phone
  • English speaking

You may not qualify if:

  • Diagnosis of ASD
  • Past year psychiatric hospitalization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02215, United States

Location

Related Publications (1)

  • Kuhlthau KA, Traeger L, Luberto CM, Perez GK, Goshe BM, Fell L, Iannuzzi D, Park ER. Resiliency Intervention for Siblings of Children With Autism Spectrum Disorder: A Randomized Pilot Trial. Acad Pediatr. 2023 Aug;23(6):1187-1195. doi: 10.1016/j.acap.2022.11.011. Epub 2022 Nov 30.

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Karen A Kuhlthau, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2020

First Posted

April 30, 2020

Study Start

January 28, 2020

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

April 5, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations